SCHEMBL19106291

SCHEMBL19106291

c1ccc(-c2nc(-c3cccc(-c4cccc(-c5nc(-c6ccccc6)c6sc7ccccc7c6n5)c4)c3)c3ccc4ccccc4c3n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ RECQL P46063 2/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ MMP14 P50281 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ CYP1A1 P04798 2/20 0.36
▸ CYP1B1 Q16678 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ WHR1 P49842 1/20 0.35
▸ ATM Q13315 1/20 0.34
▸ LIMK1 P53667 4/20 0.34
▸ LIMK2 P53671 1/20 0.34
▸ RORB Q92753 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ TNKS O95271 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18158388 0.98 MAPT (0.39) MEN1KMT2ALMNAMAPTRECQL
SCHEMBL18158382 0.98 MAPT (0.39) MEN1KMT2ALMNAMAPTRECQL
SCHEMBL18158387 0.98 MAPT (0.39) MEN1KMT2ALMNAMAPTRECQL
SCHEMBL18158386 0.97 MAPT (0.39) MEN1KMT2ALMNAMAPTRECQL
SCHEMBL18018297 0.91 WHR1 (0.38) MEN1KMT2ALMNAMAPTRECQL
SCHEMBL18017664 0.91 WHR1 (0.38) MEN1KMT2ALMNAMAPTRECQL
SCHEMBL18017723 0.91 WHR1 (0.38) MEN1KMT2ALMNAMAPTRECQL
SCHEMBL18017647 0.89 WHR1 (0.39) MEN1KMT2ALMNAMAPTRECQL
SCHEMBL19106348 0.89 CYP1A1 (0.37) MEN1KMT2ALMNAMAPTRECQL
SCHEMBL24222797 0.89 CYP1A1 (0.35) MEN1KMT2ALMNAMAPTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same DUK SAN NEOLUX CO., LTD (KR) 2020-08-04 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NFE2L2, ESR1, VDAC2 MEN1 1003/4885KMT2A 581/4885LMNA 2514/4885
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same NFE2L2, ESR1, VDAC2 MEN1 1003/4885KMT2A 581/4885LMNA 2514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback